Use of a3 adenosine receptor agonists for the preparation of compositions for reducing intraocular pressure and such compositions

摘要

The present disclosure provides the use of an A3R agonist, such as IB-MECA, for reducing in a subject, preferably, human subject, intra ocular pressure (IOP). Similarly, the invention provides a pharmaceutical composition and a method for reducing IOP in a subject making use of the A3R agonist.